No such associations have been reported in subsequent clinical trials (as would be expected if these were drug-related adverse events), although the prescribing information notes the imbalance in the number of cases between treatment groups in the early studies, and states that the agent should not be used in patients with active bladder cancer, and should be used with caution in those with a prior history [74]
There are no secondary ingredients, no proprietary blends, no undisclosed additives
Giridhar-Gohal, who has spent the last 25 years working in FMCG and retail with global corporations such as Diageo and PepsiCo, says there are opportunities for companies that can develop products that deliver high nutritional value in smaller formats, such as protein-forward snacks, fibre-rich foods that support satiety, portion-controlled products, and nutrient-dense mini-meals or functional beverages
For people struggling with weight management who've tried diet and exercise without lasting results, the rise of GLP-1 medications has created a new category of options
.webp)
